Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

被引：0
|
作者：
Peter A Fasching
Katharina Heusinger
Lothar Haeberle
Melitta Niklos
Alexander Hein
Christian M Bayer
Claudia Rauh
Ruediger Schulz-Wendtland
Mayada R Bani
Michael Schrauder
Laura Kahmann
Michael P Lux
Johanna D Strehl
Arndt Hartmann
Arno Dimmler
Matthias W Beckmann
David L Wachter
机构：
[1] University of California at Los Angeles,Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine
[2] Erlangen University Hospital,Department of Gynecology and Obstetrics
[3] Erlangen University Hospital,Institute of Diagnostic Radiology
[4] Erlangen University Hospital,Institute of Pathology
[5] St Vincentius Hospital,Institute of Pathology
来源：
BMC Cancer | / 11卷
关键词：
Overall Survival; Trastuzumab; Molecular Subtype; HER2 Status; Molecular Subgroup;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    BMC CANCER, 2011, 11
  • [2] Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
    Jain, Parveen
    Doval, Dinesh Chandra
    Batra, Ullas
    Goyal, Pankaj
    Bothra, Sneha Jatan
    Agarwal, Chaturbhuj
    Choudhary, Dutta Kumardeep
    Yadav, Abhishek
    Koyalla, Venkata Pradeep Babu
    Sharma, Mansi
    Dash, Prashanta
    Talwar, Vineet
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (04) : 329 - 338
  • [3] Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes?
    Sueta, Aiko
    Yamamoto, Yutaka
    Hayashi, Mitsuhiro
    Yamamoto, Satoko
    Inao, Toko
    Ibusuki, Mutsuko
    Murakami, Keiichi
    Iwase, Hirotaka
    SURGERY, 2014, 155 (05) : 927 - 935
  • [4] Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Montemurro, Filippo
    Di Cosimo, Serena
    BREAST, 2014, 23 (05) : 690 - 691
  • [5] Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence
    Liu, Yuexi
    Gu, Qiuying
    Xiao, Yao
    Wei, Xing
    Wang, Jinlong
    Huang, Xiaolan
    Linghu, Hua
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 761 - 769
  • [6] Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
    Chen, Rui
    Ye, Yin
    Yang, Chengcheng
    Peng, Yang
    Zong, Beige
    Qu, Fanli
    Tang, Zhenrong
    Wang, Yihua
    Su, Xinliang
    Li, Hongyuan
    Yang, Guanglun
    Liu, Shengchun
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (01) : 35 - 43
  • [7] Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?
    Dave, Sukruti
    Choudhury, Arpan
    Alurkar, Shirish S.
    Shah, Akash M.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (01) : 44 - 52
  • [8] Expressions of Topo IIα and Ki67 in breast cancer and its clinicopathologic features and prognosis
    Sun, Guangyu
    Wang, Shuyan
    Wang, Ying
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2019, 35 (03) : 715 - 720
  • [9] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
  • [10] Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Tao, Miaomiao
    Chen, Shu
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2017, 96 (51)
12345